Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
| Quarter | Letter Date | Fund Name | QTD | YTD | Tickers | Themes | Quick Take |
|---|---|---|---|---|---|---|---|
Buyside Digest is not affiliated with, and does not endorse, Harris Associates International Equity Strategy. This analysis is provided for institutional research purposes only and is not investment advice.
"The Oakmark International Strategy outperformed its benchmark in Q2 2025 with a 12.82% net return, aggressively deploying capital into dominant franchises like ASML on short-term weakness while declaring the death of the U.S. growth outperformance era."
In Q2 2025, the Oakmark International Strategy returned 12.82% net of fees, outperforming the MSCI World ex USA Index's return of 12.05%. Top performance contributors included KB Financial Group, Continental, and Bayer, while major detractors were Alibaba Group, Worldline, and LVMH. The fund actively reallocated capital during the quarter, establishing new positions in ASML, ASR Nederland, and SMC while entirely exiting six long-held positions. The manager expresses high conviction in a fundamental market regime shift away from overvalued U.S. growth/momentum stocks toward attractively valued international and European equities.
Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.
Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.
Market Conviction
High-conviction positioning: The Oakmark International Strategy outperformed its benchmark in Q2 2025 with a 12.82% net return, aggressively deploying capital into dominant franchises like ASML on short-term w...
Growth Outlook
Market outlook remains high conviction: The Oakmark International Strategy outperformed its benchmark in Q2 2025 with a 12.82% net return, aggressively deploying capital into dominant franchises like ASML on short-term w...
Risk Appetite
Risk appetite posture is above average conviction: The Oakmark International Strategy outperformed its benchmark in Q2 2025 with a 12.82% net return, aggressively deploying capital into dominant franchises like ASML on short-term w...
Capital Deployment
Manager actively deployed capital into high-conviction opportunities. The Oakmark International Strategy outperformed its benchmark in Q2 2025 with a 12.82% net return, aggressively deploying capital into dominant franchises like ASML on short-term w...
Forward Guidance
Forward guidance signal: The Oakmark International Strategy outperformed its benchmark in Q2 2025 with a 12.82% net return, aggressively deploying capital into dominant franchises like ASML on short-term w...
Language Signal
Tone analysis indicates high conviction language: The Oakmark International Strategy outperformed its benchmark in Q2 2025 with a 12.82% net return, aggressively deploying capital into dominant franchises like ASML on short-term w...
Perceived Risk
Perceived risk level is evaluated as moderate conviction. The Oakmark International Strategy outperformed its benchmark in Q2 2025 with a 12.82% net return, aggressively deploying capital into dominant franchises like ASML on short-term w...
Opportunity Density
Opportunity density index indicates high conviction actionable entry points. The Oakmark International Strategy outperformed its benchmark in Q2 2025 with a 12.82% net return, aggressively deploying capital into dominant franchises like ASML on short-term w...
Time Horizon
Investment time horizon reflects a high conviction orientation. The Oakmark International Strategy outperformed its benchmark in Q2 2025 with a 12.82% net return, aggressively deploying capital into dominant franchises like ASML on short-term w...
